EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles

Yili Ding, Shufeng Xu, Charles Ding, Zhiyuan Zhang, Zhe Xu

Molecules · 2024

DOI: 10.3390/molecules29091915 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Yili Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou 325060, China. Hauptthemen laut MEDLINE: Ketoconazole, beta-Cyclodextrins, Solubility, Antifungal Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Entrepreneurship Team Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a powerful imidazole antifungal drug, ketoconazole’s low solubility (0.017 mg/mL), together with its odor and irritation, limited its clinical applications. The inclusion complex of ketoconazole with randomly methylated β-cyclodextrin was prepared by using an aqueous solution method after cyclodextrin selection through phase solubility studies, complexation methods, and condition selection through single factor and orthogonal strategies. The complex was confirmed by FTIR (Fourier-transform infrared spectroscopy), DSC (differential scanning calorimetry), TGA (thermogravimetric analysis), SEM (scanning electron microscope images), and NMR (Nuclear magnetic resonance) studies. Through complexation, the water solubility of ketoconazole in the complex was increased 17,000 times compared with that of ketoconazole alone, which is the best result so far for the ketoconazole water solubility study. In in vitro pharmacokinetic studies, ketoconazole in the complex can be 100% released in 75 min, and in in vivo pharmacokinetic studies in dogs, through the complexation, the Cmax was increased from 7.56 μg/mL to 13.58 µg/mL, and the AUC0~72 was increased from 22.69 μgh/mL to 50.19 μgh/mL, indicating that this ketoconazole complex can be used as a more efficient potential new anti-fungal drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ketoconazolebeta-CyclodextrinsSolubilityAntifungal AgentsAnimalsDogsCalorimetry, Differential ScanningSpectroscopy, Fourier Transform InfraredMethylation

Stichwörter der Autor:innen

in vitro and in vivo pharmacokinetic studyinclusion complexketoconazolerandomly methylated β-cyclodextrinwater solubility

Substanzen

Ketoconazolebeta-CyclodextrinsAntifungal Agents

Autor:innen und Institutionen

  • College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou 325060, China.
  • Dorothy and George Hennings College of Science, Mathematics and Technology, Kean University, 1000 Morris Ave, Union, NJ 07083, USA.
  • Life Science Department, Foshan University, Foshan 528000, China.
  • Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.

Förderung

  • Innovation and Entrepreneurship Team Project

Zitieren

APA

Ding, Y., Xu, S., Ding, C., Zhang, Z., & Xu, Z. (2024). Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles. Molecules. https://doi.org/10.3390/molecules29091915

Vancouver

Ding Y, Xu S, Ding C, Zhang Z, Xu Z. Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles. Molecules. 2024. doi:10.3390/molecules29091915

BibTeX
@article{Ding2024,
  author = {Ding, Yili and Xu, Shufeng and Ding, Charles and Zhang, Zhiyuan and Xu, Zhe},
  title = {Randomly Methylated β-Cyclodextrin Inclusion Complex with Ketoconazole: Preparation, Characterization, and Improvement of Pharmacological Profiles},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29091915}
}
Kostenlos starten →